CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Two-Year Agreement to Build and Operate AssureChain

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA signed a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy and operate AssureChain, a dedicated subnet of MindChain for BlockAssure insurance and reinsurance operations. MindWave will design, develop, security-audit and deploy AssureChain, then host, operate and maintain the network, which will support contracts, policies, premium and payment entries, reinsurance treaties and claims processing. MindChain will provide the settlement layer and anchor AssureChain records to Ethereum.

Under the agreement, MindWave will receive contracted development fees payable in quarterly installments, with operating and maintenance fees to be agreed, as well as an allocation equal to 20% of the total supply of AssureCoin, a planned digital token within the MindChain network. MindWave will serve as BlockAssure exclusive blockchain provider for AssureChain during the agreement. The agreement took effect Oct. 4, 2026, with development planned over four quarters, and will automatically renew for one-year periods following the initial two-year term unless either party provides 90 days notice.

To view the full press release, visit https://ccw.fm/bVeq4

About MindWave Innovations Inc. USA

MindWave Innovations Inc. USA, a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), develops technology infrastructure and digital solutions for blockchain-enabled applications, data-driven platforms, and emerging commercial ecosystems.

Through projects such as AssureChain, MindWave is expanding the application of its technology into insurance, reinsurance and digital-asset-enabled insurance models.

About MindChain

MindChain is a blockchain infrastructure developed within the MindWave ecosystem to support transparent, traceable, and verifiable digital transactions. It is designed to provide the underlying ledger capabilities required for applications involving digital assets, registries, tokenized ecosystems, and decentralized services.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://cnw.fm/APUS

About CryptoCurrencyWire

CryptoCurrencyWire (“CCW”) is a specialized communications platform with a focus on blockchain and the cryptocurrency sector. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled recognition and brand awareness. CCW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire website applicable to all content provided by CCW, wherever published or re-published: https://www.CryptoCurrencyWire.com/Disclaimer

CryptoCurrencyWire
Austin, Texas
www.CryptoCurrencyWire.com
512.354.7000 Office
[email protected]

CryptoCurrencyWire is powered by IBN

This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Two-Year Agreement to Build and Operate AssureChain.